Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian cancer

N Einhorn

    Acta Oncologica (Stockholm, Sweden)
    |January 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Radiotherapy shows promise for minimal residual ovarian cancer after surgery, potentially improving survival. Its role in advanced stages remains controversial, with evidence supporting its use in specific consolidation treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005
    Same author

    Laminin-5 gamma 2 chain as an invasivity marker for uni- and multifocal lesions in the lower anogenital tract.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2002
    Same author

    Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.

    European journal of cancer (Oxford, England : 1990)·2001
    Same author

    D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study.

    Anti-cancer drugs·2001
    Same author

    Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

    Lancet (London, England)·2001
    Same author

    Long-term follow-up of the Stockholm screening study on ovarian cancer.

    Gynecologic oncology·2000

    Area of Science:

    • Oncology
    • Radiation Oncology

    Background:

    • Ovarian cancer treatment primarily involves surgery for early stages.
    • The efficacy of adjuvant therapies like chemotherapy or radiotherapy is not definitively established.
    • Tumor volume significantly influences radiotherapy outcomes.

    Purpose of the Study:

    • To synthesize existing literature on the role of radiotherapy in ovarian cancer treatment.
    • To evaluate the effectiveness of radiotherapy based on tumor stage and residual disease.
    • To clarify the controversial aspects of radiotherapy in advanced ovarian cancer.

    Main Methods:

    • Comprehensive literature review of 74 scientific articles.
    • Inclusion of randomized, prospective, and retrospective studies.
    • Analysis of data from 6,140 patients.

    Related Experiment Videos

    Main Results:

    • Surgery is the standard for early-stage (I-II) ovarian cancer; adjuvant treatment value is unproven.
    • Radiotherapy can be effective for microscopic or small residual disease post-surgery, improving survival.
    • Evidence for radiotherapy in advanced ovarian cancer is conflicting, though it may aid consolidation in remission.

    Conclusions:

    • Radiotherapy is beneficial for minimal residual ovarian cancer after surgery.
    • Its role in advanced stages requires further investigation, particularly for consolidation therapy.
    • Palliative radiotherapy is indicated for larger residual tumor volumes.